For now, there’s no hard and fast rule when it comes to the slippery slope CBD companies will have to contend with until the FDA starts approving products. Until then, it’s best to err on the side of caution and avoid making any claims you can’t back up with hard science and cited studies, lest draw the ire of government officials who can and will put you out of business if you don’t heed their warnings.
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…
By gently heating your plant matter instead of setting it on fire, a vaporizer extracts…
For the past five years, Texas has lived in a strange legal limbo. The 2018…
Thirty years after Prop 215, the California State Fair crowned its first home-grow champion and…
Senate leaders released a stopgap that would push most of the federal hemp deadline to…